Insider Trading & Ownership - Enliven Therapeutics Inc. (ELVN)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Enliven Therapeutics Inc.
Goto 0, 1, 2, ...5, 6, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-07-07
Sale
2025-07-09
7:29 pm
Enliven Therapeutics Inc.ELVNPatel Anish
CHIEF OPERATING OFFICER
6,667$19.79$131,951296,642
(Indirect)
View
2025-06-27
Sale
2025-07-01
4:42 pm
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$20.91$67,956138,806
(Direct)
View
2025-06-20
Sale
2025-06-24
5:36 pm
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
12,500$21.4$267,458965,188
(Indirect)
View
2025-06-17
Sale
2025-06-18
6:22 pm
Enliven Therapeutics Inc.ELVNKintz Samuel
PRESIDENT AND CEO
12,500$22.18$277,292952,892
(Indirect)
View
2025-06-13
Sale
2025-06-17
4:24 pm
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,000$22.55$67,655142,056
(Direct)
View
2025-06-09
Sale
2025-06-11
6:25 pm
Enliven Therapeutics Inc.ELVNPatel Anish
CHIEF OPERATING OFFICER
6,667$20.34$135,574303,309
(Indirect)
View
2025-06-03
Sale
2025-06-05
4:55 pm
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
7,500$20.03$150,220977,688
(Indirect)
View
2025-06-03
Sale
2025-06-05
4:53 pm
Enliven Therapeutics Inc.ELVNKintz Samuel
PRESIDENT AND CEO
7,500$20.05$150,352965,392
(Indirect)
View
2025-05-27
Sale
2025-05-29
5:38 pm
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$16.18$52,593145,056
(Direct)
View
2025-05-19
Sale
2025-05-21
6:31 pm
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
5,000$16.31$81,534985,188
(Indirect)
View
2025-05-19
Sale
2025-05-21
6:29 pm
Enliven Therapeutics Inc.ELVNKintz Samuel
PRESIDENT AND CEO
5,000$16.49$82,453972,892
(Indirect)
View
2025-05-07
Sale
2025-05-09
6:48 pm
Enliven Therapeutics Inc.ELVNPatel Anish
CHIEF OPERATING OFFICER
6,667$18.39$122,579309,976
(Indirect)
View
2025-05-01
Sale
2025-05-05
6:43 pm
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
7,500$20.05$150,391990,188
(Indirect)
View
2025-05-01
Sale
2025-05-05
6:42 pm
Enliven Therapeutics Inc.ELVNKintz Samuel
PRESIDENT AND CEO
7,500$20.06$150,415977,892
(Indirect)
View
2025-04-28
Sale
2025-04-30
6:59 pm
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$18.69$60,738148,306
(Direct)
View
2025-04-21
Sale
2025-04-23
5:09 pm
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
5,000$16.07$80,366997,688
(Indirect)
View
2025-04-17
Sale
2025-04-21
5:55 pm
Enliven Therapeutics Inc.ELVNKintz Samuel
PRESIDENT AND CEO
5,000$16.42$82,096985,392
(Indirect)
View
2025-04-07
Sale
2025-04-09
4:25 pm
Enliven Therapeutics Inc.ELVNPatel Anish
CHIEF OPERATING OFFICER
6,667$18.04$120,269316,643
(Indirect)
View
2025-03-27
Sale
2025-03-31
7:37 pm
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$21.33$69,321151,556
(Direct)
View
2025-03-24
Sale
2025-03-26
7:37 pm
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
1,000$22.5$22,505154,806
(Direct)
View
2025-03-19
Sale
2025-03-21
5:49 pm
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
12,500$20.61$257,5751,002,688
(Indirect)
View
2025-03-17
Sale
2025-03-19
5:42 pm
Enliven Therapeutics Inc.ELVNKintz Samuel
PRESIDENT AND CEO
12,500$20.83$260,320990,392
(Indirect)
View
2025-03-07
Sale
2025-03-11
5:18 pm
Enliven Therapeutics Inc.ELVNPatel Anish
CHIEF OPERATING OFFICER
6,667$21.44$142,936323,310
(Indirect)
View
2025-02-27
Sale
2025-03-03
8:07 pm
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$20.41$66,327155,806
(Direct)
View
2025-02-07
Sale
2025-02-10
5:32 pm
Enliven Therapeutics Inc.ELVNPatel Anish
CHIEF OPERATING OFFICER
6,667$21.93$146,206500,977
(Indirect
Direct)
View
2025-02-05
Sale
2025-02-07
7:06 pm
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
1,000$22.52$22,524159,056
(Direct)
View
2025-01-27
Sale
2025-01-29
7:21 pm
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$21.59$70,178160,056
(Direct)
View
2025-01-07
Sale
2025-01-10
5:31 pm
Enliven Therapeutics Inc.ELVNPatel Anish
CHIEF OPERATING OFFICER
28,367$24.18$685,868381,880
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-06-27
Exercise
2025-07-01
4:42 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$2.48138,806
(Direct)
View
2025-06-27
Exercise
2025-07-01
4:42 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$0138,806
(Direct)
View
2025-06-13
Exercise
2025-06-17
4:24 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,000$2.48142,056
(Direct)
View
2025-06-13
Exercise
2025-06-17
4:24 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,000$0142,056
(Direct)
View
2025-05-27
Exercise
2025-05-29
5:38 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$2.48145,056
(Direct)
View
2025-05-27
Exercise
2025-05-29
5:38 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$0145,056
(Direct)
View
2025-04-28
Exercise
2025-04-30
6:59 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$2.48148,306
(Direct)
View
2025-04-28
Exercise
2025-04-30
6:59 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$0148,306
(Direct)
View
2025-03-27
Exercise
2025-03-31
7:37 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$2.48151,556
(Direct)
View
2025-03-27
Exercise
2025-03-31
7:37 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$0151,556
(Direct)
View
2025-03-24
Exercise
2025-03-26
7:37 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
1,000$2.48154,806
(Direct)
View
2025-03-24
Exercise
2025-03-26
7:37 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
1,000$0154,806
(Direct)
View
2025-03-04
Exercise
2025-03-06
6:02 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
10,000$2.48155,806
(Direct)
View
2025-03-04
Exercise
2025-03-06
6:02 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
10,000$0155,806
(Direct)
View
2025-02-27
Exercise
2025-03-03
8:07 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$2.48155,806
(Direct)
View
2025-02-27
Exercise
2025-03-03
8:07 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$0155,806
(Direct)
View
2025-02-06
Option Award
2025-02-10
5:40 pm
N/A
2035-02-06
Enliven Therapeutics Inc.ELVNPhillips Andrew John
Director
20,491$020,491
(Direct)
View
2025-02-06
Option Award
2025-02-10
5:39 pm
N/A
2035-02-06
Enliven Therapeutics Inc.ELVNKunkel Lori Anne
Director
15,368$015,368
(Direct)
View
2025-02-06
Option Award
2025-02-10
5:38 pm
N/A
2035-02-06
Enliven Therapeutics Inc.ELVNHeyman Richard A.
Director
23,014$023,014
(Direct)
View
2025-02-06
Option Award
2025-02-10
5:36 pm
N/A
2035-02-06
Enliven Therapeutics Inc.ELVNGupta Rishi
Director
10% Owner
20,491$020,491
(Direct)
View
2025-02-06
Option Award
2025-02-10
5:35 pm
N/A
2035-02-06
Enliven Therapeutics Inc.ELVNDerynck Mika K
Director
20,491$020,491
(Direct)
View
2025-02-06
Option Award
2025-02-10
5:34 pm
N/A
2035-02-06
Enliven Therapeutics Inc.ELVNBauer Jake
Director
20,491$020,491
(Direct)
View
2025-02-06
Option Award
2025-02-10
5:33 pm
N/A
2035-02-06
Enliven Therapeutics Inc.ELVNBallal Rahul D.
Director
20,491$020,491
(Direct)
View
2025-02-06
Option Award
2025-02-10
5:32 pm
N/A
2035-02-06
Enliven Therapeutics Inc.ELVNPatel Anish
CHIEF OPERATING OFFICER
171,000$0500,977
(Direct)
View
2025-02-06
Option Award
2025-02-10
5:29 pm
N/A
2035-02-06
Enliven Therapeutics Inc.ELVNLyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
171,000$0171,000
(Direct)
View
2025-02-06
Option Award
2025-02-10
5:28 pm
N/A
2035-02-06
Enliven Therapeutics Inc.ELVNKintz Samuel
PRESIDENT AND CEO
490,000$0490,000
(Direct)
View
2025-02-06
Option Award
2025-02-10
5:27 pm
N/A
2035-02-06
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
171,000$0171,000
(Direct)
View
2025-02-06
Option Award
2025-02-10
5:25 pm
N/A
2035-02-06
Enliven Therapeutics Inc.ELVNCollins Helen Louise
CHIEF MEDICAL OFFICER
171,000$0171,000
(Direct)
View
2025-02-05
Exercise
2025-02-07
7:06 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
1,000$2.48159,056
(Direct)
View
2025-02-05
Exercise
2025-02-07
7:06 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
1,000$0159,056
(Direct)
View
2025-01-27
Exercise
2025-01-29
7:21 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$2.48160,056
(Direct)
View
2025-01-27
Exercise
2025-01-29
7:21 pm
N/A
2031-08-02
Enliven Therapeutics Inc.ELVNHohl Benjamin
CHIEF FINANCIAL OFFICER
3,250$0160,056
(Direct)
View
2025-01-07
Exercise
2025-01-10
5:31 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNPatel Anish
CHIEF OPERATING OFFICER
11,000$2.48381,880
(Direct)
View
2025-01-07
Exercise
2025-01-10
5:31 pm
N/A
N/A
Enliven Therapeutics Inc.ELVNPatel Anish
CHIEF OPERATING OFFICER
10,700$1.12381,880
(Direct)
View
2025-01-07
Exercise
2025-01-10
5:31 pm
N/A
2030-06-16
Enliven Therapeutics Inc.ELVNPatel Anish
CHIEF OPERATING OFFICER
21,700$0381,880
(Direct)
View
Goto 0, 1, 2, ...5, 6, Next